Crystal structure of glutamate-1-semialdehyde-2,1-aminomutase from Arabidopsis thaliana
2024 Meta-Analysis Indicates That GLP-1RAs Reduce Adverse CV Events A 2024 Meta-analysis of 13 multiple cardiovascular outcome trials has documented that GLP1-RA therapy significantly reduces the risk of major adverse cardiovascular events (MACEs), all-cause mortality, CV mortality, stroke, risk for coronary revascularization, and composite adverse kidney outcomes in both sexes, regardless of a patient's history of cardiovascular disease, BMI or eGFR (Rivera et al, 2024)
Type in the name of the company of interest and then read through the forms
Protecting the Microbiome Understand the role of fermented foods, probiotics, and fiber in maintaining gut health during treatment.
However, the study did not report changes in BMI or HbA1c, both of which may confound IBD outcomes due to known associations between obesity, 90 diabetes, 91 and disease severity
While dietary B12 requires Intrinsic Factor for absorption, high-dose supplements (such as 5000 mcg) rely on a process called passive diffusion